Track 15: Valvular Heart Disease – Advancing Diagnosis and Treatment



5th World Cardiology and Cardiovascular Diseases Conference
Dubai, UAE | March 04–06, 2026

Valvular Heart Disease (VHD) remains one of the most pressing challenges in cardiology, affecting millions worldwide. From degenerative valve conditions to rheumatic heart disease, the burden of VHD is significant, often leading to heart failure, arrhythmias, or even life-threatening complications if not detected and treated on time.

Why Focus on Valvular Heart Disease?

Heart valves play a vital role in ensuring proper blood flow through the heart. When these valves become narrowed (stenosis) or fail to close properly (regurgitation), the heart’s efficiency is compromised. With the rise in life expectancy and cardiovascular risk factors, the incidence of VHD is steadily increasing globally.

What to Expect in Track 15

This track will explore the full spectrum of valvular heart disease management, covering:

  • Epidemiology & Risk Factors – Understanding the global burden of VHD.
  • Advances in Imaging & Diagnosis – Echocardiography, CT, and MRI for accurate assessment.
  • Surgical Interventions – Innovations in valve repair and replacement.
  • Transcatheter Therapies (TAVR, TMVR) – Minimally invasive solutions transforming patient care.
  • Pharmacological Management – Role of medical therapy in symptom relief and risk reduction.
  • Future Directions – AI, robotics, and next-gen prosthetic valves.

Who Should Attend?

This session is ideal for:

  • Cardiologists & Interventional Cardiologists
  • Cardiovascular Surgeons
  • Echocardiographers & Imaging Specialists
  • Clinical Researchers & Scientists
  • Medical Students & Residents interested in advanced cardiovascular care

Why Join Track 15 in Dubai?

By joining this track, attendees will gain insights into the latest diagnostic tools, surgical techniques, and cutting-edge transcatheter interventions that are reshaping the treatment of valvular heart disease. It’s an opportunity to connect with global experts, share research findings, and discover practical solutions that can be applied to clinical practice.

Be part of the conversation at the 5th World Cardiology and Cardiovascular Diseases Conference and learn how innovation is changing the outlook for patients with valvular heart disease.

Dubai, UAE | March 04–06, 2026

 


Comments

Post a Comment

Popular posts from this blog

Track 5: Cardio-Oncology – Where Cancer Care Meets Cardiovascular Precision

Image
5th World Cardiology and Cardiovascular Diseases Conference | March 04–06, 2026 | Dubai, UAE As cancer survival rates continue to rise, so too does a growing and urgent need to address the cardiovascular side effects of cancer therapies . At the intersection of oncology and cardiology lies the rapidly evolving field of Cardio-Oncology —the focus of Track 5 at the upcoming 5th World Cardiology and Cardiovascular Diseases Conference in Dubai, UAE . This dedicated track offers a critical platform to explore how cancer treatments impact the heart, and how healthcare professionals can work together to protect both survival and quality of life for patients. The Rising Relevance of Cardio-Oncology Life-saving cancer treatments such as chemotherapy, immunotherapy, radiation, and targeted agents often come with unintended cardiovascular risks—ranging from arrhythmias and hypertension to heart failure and myocardial ischemia. With the number of cancer survivors growing worldwide,...
Read more

Track 20: Diabetic Cardiomyopathy

Image
Track 20: Diabetic Cardiomyopathy 5th World Cardiology and Cardiovascular Diseases Conference Dubai, UAE | March 04–06, 2026 Diabetic cardiomyopathy (DCM) is a growing global concern that highlights the intricate link between diabetes and cardiovascular health . Characterized by structural and functional changes in the heart muscle in patients with diabetes—independent of coronary artery disease or hypertension—DCM is emerging as a major contributor to heart failure in diabetic populations. At the 5th World Cardiology and Cardiovascular Diseases Conference in Dubai , Track 20: Diabetic Cardiomyopathy will delve into the pathophysiology, diagnostic strategies, and therapeutic approaches to tackle this complex condition. With the rapid increase in diabetes worldwide, understanding and managing DCM is more critical than ever. Key Topics of Discussion Molecular Mechanisms – Hyperglycemia, oxidative stress, and myocardial fibrosis in DCM. Diagnosis & Imaging – The role of ech...
Read more

Track 22: Cardiac Devices and Diagnostics

Image
5th World Cardiology and Cardiovascular Diseases Conference Dubai, UAE | March 04–06, 2026 The field of cardiology has been transformed by innovative devices and advanced diagnostic technologies that enable earlier detection, more accurate monitoring, and more effective treatment of cardiovascular diseases. From wearable technologies and implantable devices to state-of-the-art imaging tools and AI-powered diagnostics , these advancements are revolutionizing patient outcomes and quality of life. At the 5th World Cardiology and Cardiovascular Diseases Conference in Dubai , Track 22: Cardiac Devices and Diagnostics will showcase the latest progress in medical devices, monitoring systems, imaging modalities, and diagnostic strategies that are shaping the future of cardiovascular care. Key Topics of Discussion Implantable Cardiac Devices – Pacemakers, defibrillators, and ventricular assist devices. Wearable & Remote Monitoring – Smartwatches, biose...
Read more